Use of adjunctive antipsychotic medications in depression

Press release from PLOS Medicine

2013-03-13

(Press-News.org) A study published this week in PLOS Medicine finds that while antipsychotic medications are associated with small-to-moderate improvements in depressive symptoms in adults, there is little evidence for improvement on measures of quality of life and these medications are linked to adverse events such as weight gain and sedation.

The results of the study, conducted by Glen Spielmans of Metropolitan State University in St. Paul, Minnesota and colleagues, have potential implications for the treatment of depression by providing clinicians with a better understanding of the risk–benefit profiles for commonly prescribed antipsychotic medications.

The authors reached these conclusions by combining the results from 14 published or unpublished randomized clinical trials (duration 4-12 weeks) comparing an adjunctive antipsychotic medication (aripiprazole, olanzapine/fluoxetine combination [OFC], quetiapine, or risperidone) to placebo in the treatment of depression that had not responded to antidepressant medication alone.

The four medications showed statistically significant small or small-to-moderate beneficial effects on depression symptoms. However, on measures of functioning and quality of life, these medications generally produced either no benefit or small benefits. In addition, treatment was linked to several adverse events, such as akathisia, sedation, abnormal metabolic laboratory results, and weight gain. The authors also comment that shortcomings in study design and reporting may have over-emphasized the apparent benefits of treatment and reduced the apparent incidence of adverse events.

The authors say: "Taken together, our meta-analysis found evidence of (1) some improvement in clinician-assessed depressive symptoms, (2) little evidence of substantial benefit in overall well-being, and (3) abundant evidence of potential treatment-related harm."

They add: "Our comprehensive evaluation of safety and both relative and absolute efficacy provides critical insight that may be useful for clinicians attempting to thoroughly understand the risk–benefit profiles of these adjunctive treatments for major depressive disorder."

Individuals treated with adjunctive antipsychotic medication who are concerned about potential side effects are urged to discuss this study with their physician before making any decisions to stop taking or change any medications.

### Funding: ACT acknowledges salary support through Mentored Patient-Oriented Research Career Development Award K23 MH-096620, US National Institute of Mental Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing Interests: GIS is a member of Healthy Skepticism and holds shares of less than $10,000 in a mutual fund (Vanguard Health Care) that invests heavily in pharmaceutical firms. NZR is a member of both the National Physicians Alliance and Healthy Skepticism. NZR is also a local site investigator on a Department of Veterans Affairs sponsored multi-site trial of treatments for resistant depression. One study arm is receiving aripiprazole augmentation. The study is receiving no funding from pharmaceutical companies. NZR is also serving as a consultant in a lawsuit against the manufacturer of aripiprazole. ACT acknowledges salary support through Mentored Patient-Oriented Research Career Development Award K23 MH-096620, US National Institute of Mental Health. ACT is a former board member of the ethics committee, and former member, of the National Physicians Alliance. GIS had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. No specific funding was provided to support the conduct of this meta-analysis. The authors declare no other competing interests.

Citation: Spielmans GI, Berman MI, Linardatos E, Rosenlicht NZ, Perry A, et al. (2013) Adjunctive Atypical Antipsychotic Treatment for Major Depressive Disorder: A Meta-Analysis of Depression, Quality of Life, and Safety Outcomes. PLoS Med 10(3): e1001403. doi:10.1371/journal.pmed.1001403

IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER:

http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001403

Contact:

Glen I. Spielmans
Department of Psychology
Metropolitan State University
St. Paul, Minnesota, United States of America,
glen.spielmans@metrostate.edu END

ELSE PRESS RELEASES FROM THIS DATE:

Ethical oversight needed for social network health research

2013-03-13

Participant-led research, such as studies conducted via social networks, are increasingly common and have several advantages over more standard research but there are some concerns about their ethical oversight, according to experts writing in this week's PLOS Medicine. Effy Vayena from the University of Zurich in Switzerland and John Tasioulas from University College London argue that the distinctive nature of such participant-led research means that the standards of ethical oversight should be adapted to strike a balance between protecting the interests of research ...

Implementing e-health in Malawi

2013-03-13

In low-income countries a substantial challenge in planning and delivering healthcare is the accurate assessment of disease burden. In this week's PLOS Medicine, Miguel SanJoaquin from the University of Malawi College of Medicine and colleagues describe their experience of implementing an electronic patient record system in a large referral hospital in southern Malawi. The system, known as Surveillance Programme of IN-patients and Epidemiology (SPINE), is used to record patient details during consultations and this data can be used to monitor changing patterns of disease ...

Using fat to fight brain cancer

2013-03-13

In laboratory studies, Johns Hopkins researchers say they have found that stem cells from a patient's own fat may have the potential to deliver new treatments directly into the brain after the surgical removal of a glioblastoma, the most common and aggressive form of brain tumor. The investigators say so-called mesenchymal stem cells (MSCs) have an unexplained ability to seek out damaged cells, such as those involved in cancer, and may provide clinicians a new tool for accessing difficult-to-reach parts of the brain where cancer cells can hide and proliferate anew. The ...

Despite weight gain, quitting smoking associated with reduced risk of cardiovascular disease

2013-03-13

Among adults without diabetes, quitting smoking, compared with continuing smoking, was associated with a lower risk of cardiovascular disease despite subsequent weight gain, according to a study appearing in the March 13 issue of JAMA. "Cigarette smoking is the leading cause of preventable mortality in the United States and a major risk factor for cardiovascular disease (CVD). Smoking cessation substantially reduces the risks of CVD; however, quitting smoking is associated with a small number of adverse health consequences, weight gain being one of smokers' major concerns," ...

Duration of breastfeeding during infancy does not reduce a child's risk of being overweight, obese

2013-03-13

In research that included nearly 14,000 healthy infants in Belarus, an intervention that succeeded in improving the duration and exclusivity of breastfeeding during infancy did not result in a lower risk of overweight or obesity among the children at age 11.5 years, according to a study appearing in the March 13 issue of JAMA. Observational studies suggest that greater duration and exclusivity of having been breastfed reduces child obesity risk. "However, breastfeeding and growth are socially patterned in many settings," and observed associations between these variables ...

Study examines outcomes for treatment of sleep apnea with primary care vs. specialist care

2013-03-13

Among patients who were identified as likely having moderate to severe obstructive sleep apnea, treatment based in primary care was not clinically inferior to treatment at a specialist sleep center for improvement in daytime sleepiness scores, according to a study appearing in the March 13 issue of JAMA. "Obstructive sleep apnea with accompanying daytime sleepiness was estimated during the early 1990s to affect between 2 percent and 4 percent of middle-aged adults. With growing awareness of the public health implications of untreated disease and rising obesity rates ...

Major bleeding following PCI associated with increased risk of death

2013-03-13

In a study that included 3.3 million percutaneous coronary intervention (PCI; procedures such as balloon angioplasty or stent placement used to open narrowed coronary arteries) procedures, major bleeding after PCI was associated with significantly increased in-hospital mortality, with an estimated 12 percent of deaths after PCI related to bleeding complications, according to a study appearing in the March 13 issue of JAMA. "Bleeding represents the most common noncardiac complication of PCI. Postprocedural bleeding is associated with short- and long-term death, nonfatal ...

Weight gain after quitting smoking does not negate health benefits

2013-03-13

An analysis of data from the Framingham Offspring Study – a long-term study that follows children of participants in the original Framingham Heart Study – may have answered a question that has troubled individuals considering stopping smoking: do the health effects of any weight gained after quitting outweigh the known cardiovascular benefits of smoking cessation? The report in the March 13 issue of JAMA concludes that the benefits of stopping smoking far exceed any weight-gain associated risk. "Among people without diabetes, those who stopped smoking had a 50 percent ...

Fertility after ectopic pregnancy: Study finds reassuring evidence on different treatments

2013-03-13

The first randomised trial to compare treatments for ectopic pregnancies has found no significant differences in subsequent fertility between medical treatment and conservative surgery on one hand, and conservative or radical surgery on the other. The study, which is published online today (Wednesday) in Europe's leading reproductive medicine journal Human Reproduction [1], compared three ways of treating an ectopic pregnancy: medically by methotrexate injection to interrupt pregnancy in the Fallopian tube; conservative surgery, which preserves the Fallopian tube (known ...

Researchers find link between low cognitive score and risk of brain injury

2013-03-13

It is estimated that there are 10 million cases of traumatic brain injury globally every year with mild traumatic brain injuries being responsible for 70-90% of these. Incidence is highest among young males. Current literature suggests that mild traumatic brain injuries cause changes in brain tissues and have important long-term consequences on cognitive function. Deficits have been described in attention, memory, verbal learning and processing speed and may occur in 15-25% of those suffering one of these injuries. However, little is known about population-wide cognitive ...

LAST 30 PRESS RELEASES:

The American Society of Tropical Medicine and Hygiene and the Bill & Melinda Gates Foundation announce new research fellowship in malaria genomics in honor of professor Dominic Kwiatkowski